Nuvectis Pharma Statistics
Total Valuation
NVCT has a market cap or net worth of $127.39 million. The enterprise value is $106.64 million.
Market Cap | 127.39M |
Enterprise Value | 106.64M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, before market open.
Earnings Date | Aug 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
NVCT has 18.36 million shares outstanding. The number of shares has increased by 12.46% in one year.
Shares Outstanding | 18.36M |
Shares Change (YoY) | +12.46% |
Shares Change (QoQ) | +2.21% |
Owned by Insiders (%) | 54.13% |
Owned by Institutions (%) | 13.70% |
Float | 6.35M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 8.99 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.46, with zero debt.
Current Ratio | 3.46 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -141.60% and return on invested capital (ROIC) is -165.40%.
Return on Equity (ROE) | -141.60% |
Return on Assets (ROA) | -104.00% |
Return on Capital (ROIC) | -165.40% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.72M |
Employee Count | 13 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.19% in the last 52 weeks. The beta is 0.45, so NVCT's price volatility has been lower than the market average.
Beta (5Y) | 0.45 |
52-Week Price Change | -54.19% |
50-Day Moving Average | 6.55 |
200-Day Moving Average | 7.85 |
Relative Strength Index (RSI) | 50.07 |
Average Volume (20 Days) | 99,743 |
Short Selling Information
The latest short interest is 884,188, so 4.82% of the outstanding shares have been sold short.
Short Interest | 884,188 |
Short Previous Month | 1.08M |
Short % of Shares Out | 4.82% |
Short % of Float | 13.93% |
Short Ratio (days to cover) | 6.74 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -23.19M |
Pretax Income | -22.38M |
Net Income | -22.38M |
EBITDA | -22.38M |
EBIT | -22.38M |
Earnings Per Share (EPS) | -$1.41 |
Balance Sheet
The company has $19.46 million in cash and no debt, giving a net cash position of $19.46 million or $1.06 per share.
Cash & Cash Equivalents | 19.46M |
Total Debt | n/a |
Net Cash | 19.46M |
Net Cash Per Share | $1.06 |
Equity (Book Value) | 14.02M |
Book Value Per Share | 0.76 |
Working Capital | 14.02M |
Cash Flow
Operating Cash Flow | -15.54M |
Capital Expenditures | n/a |
Free Cash Flow | -15.54M |
FCF Per Share | -$0.94 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NVCT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -12.46% |
Shareholder Yield | -12.46% |
Earnings Yield | -17.75% |
FCF Yield | -12.32% |
Analyst Forecast
The average price target for NVCT is $21.00, which is 202.59% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $21.00 |
Price Target Difference | 202.59% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |